Jia Lissa

Navigating the Unspoken: A Comprehensive Guide to Supporting Children Through a Parent’s Cancer Diagnosis

• Survivorship and Post-Treatment

Navigating the Unspoken: A Comprehensive Guide to Supporting Children Through a Parent’s Cancer Diagnosis

Jia Lissa September 29, 2026

A cancer diagnosis is rarely a solitary experience; it is a profound, life-altering event that ripples through...

Read More Read more about Navigating the Unspoken: A Comprehensive Guide to Supporting Children Through a Parent’s Cancer Diagnosis

The Next Frontier in Autoimmune Care: Adicet’s "Gamma Delta" Therapy Challenges CAR-T Status Quo

• Chemotherapy and Targeted Therapy

The Next Frontier in Autoimmune Care: Adicet’s "Gamma Delta" Therapy Challenges CAR-T Status Quo

Jia Lissa September 28, 2026

By Gwendolyn Wu | Published September 28, 2026 In the rapidly evolving landscape of regenerative medicine, the...

Read More Read more about The Next Frontier in Autoimmune Care: Adicet’s "Gamma Delta" Therapy Challenges CAR-T Status Quo

Breakthrough in Brain Tumour Diagnosis: Weeks to Hours, Revolutionising Patient Care

• Medical Research and Clinical Trials

Breakthrough in Brain Tumour Diagnosis: Weeks to Hours, Revolutionising Patient Care

Jia Lissa September 28, 2026

Nottingham, UK – In a monumental leap forward for oncology, scientists and medical professionals in Nottingham have...

Read More Read more about Breakthrough in Brain Tumour Diagnosis: Weeks to Hours, Revolutionising Patient Care

Beyond the Slide: Gilead and Nucleai Challenge the Limits of ADC Precision Medicine

• Treatment Innovations

Beyond the Slide: Gilead and Nucleai Challenge the Limits of ADC Precision Medicine

Jia Lissa September 27, 2026

The rapid ascent of antibody-drug conjugates (ADCs) has transformed the oncology landscape, offering a high-precision alternative to...

Read More Read more about Beyond the Slide: Gilead and Nucleai Challenge the Limits of ADC Precision Medicine

The Celestial Catalyst: Harnessing the Power of the Full Moon in Aries

• Integrative Oncology and Holistic Care

The Celestial Catalyst: Harnessing the Power of the Full Moon in Aries

Jia Lissa September 27, 2026

Published: September 24, 2026 | Location: Global As the Northern Hemisphere settles into the balanced, relational atmosphere...

Read More Read more about The Celestial Catalyst: Harnessing the Power of the Full Moon in Aries

Strengthening the Global Health Architecture: A Deep Dive into the WHO-Netherlands Strategic Dialogue 2024

• Breast Cancer Prevention and Lifestyle

Strengthening the Global Health Architecture: A Deep Dive into the WHO-Netherlands Strategic Dialogue 2024

Jia Lissa September 27, 2026

In an era defined by geopolitical volatility, climate-induced health crises, and a lingering post-pandemic recovery, the synergy...

Read More Read more about Strengthening the Global Health Architecture: A Deep Dive into the WHO-Netherlands Strategic Dialogue 2024

Remigromig Shows Efficacy in DME, But Tolerability Concerns Loom for MSD’s Novel Therapy

• Medical Research and Clinical Trials

Remigromig Shows Efficacy in DME, But Tolerability Concerns Loom for MSD’s Novel Therapy

Jia Lissa September 27, 2026

The highly anticipated remigromig, MSD’s groundbreaking therapy for diabetic macular edema (DME), has demonstrated non-inferiority to the...

Read More Read more about Remigromig Shows Efficacy in DME, But Tolerability Concerns Loom for MSD’s Novel Therapy

The Hidden Cost of Survival: How Chemotherapy Rewrites the Genetic Blueprint of Childhood Cancer Survivors

• Clinical Oncology Education

The Hidden Cost of Survival: How Chemotherapy Rewrites the Genetic Blueprint of Childhood Cancer Survivors

Jia Lissa September 26, 2026

For decades, platinum-based chemotherapy has stood as a cornerstone of pediatric oncology, saving countless lives and transforming...

Read More Read more about The Hidden Cost of Survival: How Chemotherapy Rewrites the Genetic Blueprint of Childhood Cancer Survivors

Balomenib Shows Sustained Glycemic Control in Type 2 Diabetes Phase Ib Trial, Paving Way for Phase IIa Development

• Medical Research and Clinical Trials

Balomenib Shows Sustained Glycemic Control in Type 2 Diabetes Phase Ib Trial, Paving Way for Phase IIa Development

Jia Lissa September 26, 2026

London, UK – [Insert Date] – Clywedog Therapeutics has announced compelling final results from its Phase Ib...

Read More Read more about Balomenib Shows Sustained Glycemic Control in Type 2 Diabetes Phase Ib Trial, Paving Way for Phase IIa Development

The Dismantling of U.S. Global Health Diplomacy: A Post-Mortem on the New Administration’s Foreign Aid Overhaul

• Breast Cancer Legislation and Policy

The Dismantling of U.S. Global Health Diplomacy: A Post-Mortem on the New Administration’s Foreign Aid Overhaul

Jia Lissa September 23, 2026

Editorial Note: Originally published in May 2025, this report has been extensively updated to reflect the evolving...

Read More Read more about The Dismantling of U.S. Global Health Diplomacy: A Post-Mortem on the New Administration’s Foreign Aid Overhaul